| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/09/2011 | EP1824475B1 Methods for purifying trans-(-)-delta9-tetrahydrocannabinol and trans-(+)-delta9-tetrahydrocannabinol |
| 03/09/2011 | EP1756140B1 Selective separation or extraction of steroidal glycosides by supercritical fluid extraction using carbon dioxide |
| 03/09/2011 | EP1748069B1 Follistatin mutant polypeptide |
| 03/09/2011 | EP1729597B1 The use of sphingolipids in the treatment and prevention of type 2 diabetes mellitus, insulin resistance and metabolic syndrome |
| 03/09/2011 | EP1499297B1 Pharmaceutical formulation comprising atorvastatin calcium |
| 03/09/2011 | EP1497279B1 Substituted indoles and their use as 5ht-reuptake inhibitors and as 5ht ligands |
| 03/09/2011 | CN201755322U Dry ice weight-reducing pellet |
| 03/09/2011 | CN1582274B Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 03/09/2011 | CN101984034A Health-care wine |
| 03/09/2011 | CN101983721A Desert cistanche calcium composition having functions of fatigue resistance and calcium supplement |
| 03/09/2011 | CN101983713A Traditional Chinese medicine for treating diabetes gout |
| 03/09/2011 | CN101983705A Traditional Chinese medicine for treating diabetic acra necrosis |
| 03/09/2011 | CN101983704A Traditional Chinese medicine for treating diabetic foot |
| 03/09/2011 | CN101983700A Chinese herbal medicine compound stag blood powder and making method thereof |
| 03/09/2011 | CN101983692A Medicine for treating hyperlipemia and preparation method thereof |
| 03/09/2011 | CN101983691A Traditional Chinese medicine for treating diabetic constipation |
| 03/09/2011 | CN101983688A Drug for treating diabetes and preparation method thereof |
| 03/09/2011 | CN101983683A Traditional Chinese medicine for treating diabetic pruritus |
| 03/09/2011 | CN101983673A Traditional Chinese medicine for treating diabetic gastroparesis |
| 03/09/2011 | CN101983671A Traditional Chinese medicine for treating diabetic peripheral neuropathy |
| 03/09/2011 | CN101983663A Traditional Chinese medicine for treating diabetic nephropathy |
| 03/09/2011 | CN101983658A Traditional Chinese medicine composition for treating diabetes and preparation method thereof |
| 03/09/2011 | CN101983657A Traditional Chinese medicine for treating diabetic retinopathy |
| 03/09/2011 | CN101983656A Traditional Chinese medicine for treating diabetic eye disease |
| 03/09/2011 | CN101983640A Traditional Chinese medicine for treating diabetic heart disease |
| 03/09/2011 | CN101983639A Traditional Chinese medicine for treating diabetic diarrhea |
| 03/09/2011 | CN101983638A Traditional Chinese medicine for treating diabetic coronary heart disease |
| 03/08/2011 | US7902399 Fatty acids analogous |
| 03/08/2011 | US7902366 NK1 antagonists |
| 03/08/2011 | US7902361 Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy |
| 03/08/2011 | US7902180 Association between agomelatine and a thymoregulatory agent and pharmaceutical compositions containing it |
| 03/08/2011 | US7902157 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
| 03/08/2011 | US7901718 Process for the extraction, purification and enzymatic modification of soy 7S globulin α′ subunit for use as hypocholesterolemizing agent |
| 03/08/2011 | US7901683 Methods of inhibiting amyloid toxicity |
| 03/08/2011 | US7901672 Methods of making enhanced, autologous fat grafts |
| 03/08/2011 | CA2689051C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/08/2011 | CA2483764C Arsenic therapy for apls-type autoimmune lymphoproliferative syndrome in mice and humans |
| 03/08/2011 | CA2464721C Nitrogenous (tetrahydropyridyl) (alkyl) heterocycles with tnf activity |
| 03/08/2011 | CA2460313C Bisphenylsulfanyl and sulphonate compounds and use thereof for elevating hdl cholesterol levels |
| 03/08/2011 | CA2446756C Thiazole compounds useful as inhibitors of protein kinase |
| 03/08/2011 | CA2440355C Fibrate-statin combinations with reduced fed-fasted effects |
| 03/08/2011 | CA2432126C Complex of modafinil and cyclodextrin |
| 03/08/2011 | CA2423336C Stabilised fibrate microparticles |
| 03/08/2011 | CA2415396C 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 03/08/2011 | CA2343840C Use of a cytokine-producing lactococcus strain to treat colitis |
| 03/08/2011 | CA2329054C A novel polypeptide hormone phosphatonin |
| 03/08/2011 | CA2137377C Retinal pigmented epithelium derived neurotrophic factor |
| 03/03/2011 | WO2011025996A2 Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency |
| 03/03/2011 | WO2011025932A2 Preparation of sitagliptin and salts thereof |
| 03/03/2011 | WO2011025006A1 Gpr119 agonist |
| 03/03/2011 | WO2011024962A1 Therapeutic agent for liver-related diseases |
| 03/03/2011 | WO2011024932A1 Novel tetrahydroisoquinoline compounds |
| 03/03/2011 | WO2011024918A1 Antiangiogenic agent and method for inhibition of angiogenesis |
| 03/03/2011 | WO2011024763A1 Prophylaxis, therapeutic agent, or anorexiant for diabetes |
| 03/03/2011 | WO2011024468A1 Novel sulfonamide derivative and pharmaceutical product containing same |
| 03/03/2011 | WO2011024354A1 Transdermal composition of phosphatidylcholine and method for producing same |
| 03/03/2011 | WO2011024001A1 Np-1 antagonists and their therapeutic use |
| 03/03/2011 | WO2011023722A1 Novel quinoxalinone hepcidin antagonists |
| 03/03/2011 | WO2011023585A1 Piperidine derivatives used as orexin antagonists |
| 03/03/2011 | WO2011023578A1 5-methyl-piperidine derivatives as orexin receptor antagonists for the treatment of sleep disorder |
| 03/03/2011 | WO2011023081A1 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors |
| 03/03/2011 | WO2011022944A1 Use of lanostanes and extracts from poria cocos for treating diabetes |
| 03/03/2011 | WO2011022843A1 Use of a holotoxin to reduce endoplasmic reticulum-associated degradation of misfolded proteins |
| 03/03/2011 | WO2011000563A4 Eltoprazine for the treatment of weight disorders |
| 03/03/2011 | WO2010150901A9 Mutant for increasing oleic acid content of soybean oil and fat, and responsible gene therefor |
| 03/03/2011 | WO2010140165A4 A novel antidiabetic furostanolic saponin rich (fsr) fraction from fenugreek seeds |
| 03/03/2011 | WO2010128788A3 Anti-obesity external dermal agent compositions containing capsaicin or capsaicin-like compounds as active ingredients |
| 03/03/2011 | WO2010128528A9 Piperidine derivatives useful for treatment of diebetes |
| 03/03/2011 | WO2010123838A3 Novel amide and amidine derivatives and uses thereof |
| 03/03/2011 | WO2010117233A3 Stable pharmaceutical composition containing fluvastatin and method for manufacturing the same |
| 03/03/2011 | WO2010091241A3 Compositions and methods for promoting the generation of definitive endoderm |
| 03/03/2011 | WO2008129358A3 Oil producing microbes and methods of modification thereof |
| 03/03/2011 | WO2008065408A9 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 03/03/2011 | US20110055942 Single domain TDF-related compounds and analogs thereof |
| 03/03/2011 | US20110054029 Water-soluble dietary fatty acids |
| 03/03/2011 | US20110054011 RNA Antagonist Compounds for the Modulation of FABP4/AP2 |
| 03/03/2011 | US20110053993 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents |
| 03/03/2011 | US20110053990 Fatty acid niacin conjugates and their uses |
| 03/03/2011 | US20110053983 (5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activity |
| 03/03/2011 | US20110053978 Therapeutic uses of compounds having affinity to the serotonin transporter, serotonin receptors and noradrenalin transporter |
| 03/03/2011 | US20110053976 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 03/03/2011 | US20110053974 Carboxylic acid compound |
| 03/03/2011 | US20110053973 Compounds as tyrosine kinase modulators |
| 03/03/2011 | US20110053962 Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition |
| 03/03/2011 | US20110053961 Substituted xanthine derivatives |
| 03/03/2011 | US20110053960 Method for treating pain syndrome and other disorders |
| 03/03/2011 | US20110053959 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 03/03/2011 | US20110053958 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 03/03/2011 | US20110053943 CARBAMATE AND UREA INHIBITORS OF 11ß-HYDROXYSTEROID DEHYDROGENASE 1 |
| 03/03/2011 | US20110053931 Quinoline compounds and methods of use |
| 03/03/2011 | US20110053920 Substituted bicyclic pyrimidines |
| 03/03/2011 | US20110053911 Tricyclic derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
| 03/03/2011 | US20110053910 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
| 03/03/2011 | US20110053908 Azetidine-derived compounds, preparation method therefor and therapeutic use of same |
| 03/03/2011 | US20110053905 Compounds as tyrosine kinase modulators |
| 03/03/2011 | US20110053899 Use of lanostane and poria extract in treating diabetes |
| 03/03/2011 | US20110053889 Prenatal and postnatal screening and treatment of critical monosaccharide deficiencies for neurologic and immunologic function |
| 03/03/2011 | US20110053888 Mixture Of Carboyhydrates And Its Use In The Preparation Of A Product Intended For Oral Or Enteral Nutrition |
| 03/03/2011 | US20110053872 Pharmaceutical Composition For Preventing And Treating Diabetic Nephropathy And The Preparation Method Thereof |
| 03/03/2011 | US20110053849 Regulation of litaf modulated cytokine production by a novel p53 short peptide |